Skip to main content
Download PDF

Proteinuria may be an indicator of adverse pregnancy outcomes in patients with preeclampsia: a retrospective study

Reproductive Biology and Endocrinology volume 19, Article number: 71 (2021) Cite this article

Abstract

Background

Proteinuria is one of the common manifestations of patients with preeclampsia (PE), but whether the severity of proteinuria is related to the pregnancy outcome of patients with preeclampsia remains controversial. The present study aimed to determine the relationship between 24-h proteinuria and adverse outcomes in patients with preeclampsia.

Methods

The present retrospective study included 329 pregnant women in Chongqing, China. Patients were divided into PE group and non-PE group. PE group was stratified into three subgroups based on the level of 24-h proteinuria. Correlation analysis was used to analyze the correlation between biochemical indexes and adverse pregnancy outcome, and Logistic regression analysis was used to analyze the risk factors of adverse pregnancy outcome. The receiver operating characteristic curve (ROC) was used to evaluate the ability of 24-h urinary protein to distinguish the adverse pregnancy outcome in patients with preeclampsia.

Results

(1) Between PE and non-PE group, cesarean section rate in PE group was significantly higher than that in non-PE group (84.4% vs. 25.9%, p <  0.001). Laboratory findings such as uric acid and creatinine level in PE group were higher than those in non-PE group. (2) Among mild (proteinuria < 0.3 g/24 h), moderate (0.3 g/24 h ≦ proteinuria < 2 g/24 h) and massive (proteinuria ≧ 2 g/24 h) groups, the frequencies of induced labor (p = 0.006) and stillbirth (p = 0.002) increased with the increase of 24-h proteinuria. (3) Adverse outcomes were positively correlated with 24-h proteinuria (adverse maternal outcomes: r = 0.239, p = 0.002; adverse fetal outcomes: r = 0.336, p <  0.001). (4) The best 24-h proteinuria cutoff values to determine stillbirth, premature and fetal distress were 3965.0 mg/24 h, 984.75 mg/24 h and 1503.85 mg/24 h and their odds ratio (95% confidence interval) were 12.46 (3.46–44.88), 2.48 (1.15–5.37) and 10.02 (2.14–46.80), respectively.

Conclusions

The severity of 24-h proteinuia may forecast adverse outcomes in women with preeclampsia. We suggest proteinuria should be retained as one of the monitoring indexes in patients with preeclampsia.

Trial registration

Retrospectively registered. (LTMCMTS202001).

Background

Preeclampsia (PE), a kind of placental disease, is the most representative type of gestational hypertension. The incidence of preeclampsia accounts for 3–8% of all pregnancies, seriously affecting the health of mothers and babies [1]. Pregnant women with preeclampsia are prone to organ system dysfunction, leading to various adverse pregnancy outcomes, such as retinopathy, impaired renal function, preterm delivery, fetal growth restriction (FGR), etc. But the risk factors of adverse pregnancy outcomes need to be further explored [2,3,4]. A number of studies have shown that patients with preeclampsia should be wary of the occurrence of adverse pregnancy outcomes when massive proteinuria occurs [1, 3, 5]. In the past, the test of 24-h proteinuria was regarded as the gold standard for the diagnosis of preeclampsia in China [6]. However, proteinuria is no longer necessary for diagnosis according to guidelines issued by the American College of Obstetrics and Gynecology (ACOG) in 2013 and 2019 [7, 8]. In addition, many studies have suggested that the degree of proteinuria has nothing to do with the severity of preeclampsia, and there is no definite relationship between proteinuria and pregnancy outcome in patients with preeclampsia [9, 10]. It can be seen that the role of proteinuria in the diagnosis and evaluation of preeclampsia is still controversial. In this study, we retrospectively analyzed the relationship between 24-h proteinuria and adverse pregnancy outcome in patients with preeclampsia, and explored whether the degree of proteinuria affected the adverse pregnancy outcome in order to provide evidence for clinical diagnosis and treatment of preeclampsia.

Methods

Data sources

In present study, we retrospectively reviewed the clinical records of 329 pregnant women during January 2015 to July 2020 in Chongqing, China. There were 275 pregnant women diagnosed as preeclampsia and the other 54 pregnant women without preeclampsia were examined by obstetrics in the same period.

Design

We stratified 329 pregnant women into PE group (pregnant women with preeclampsia, n = 275) and non-PE group (pregnant women without preeclampsia, n = 54). The clinical records of pregnant women at the time of admission and delivery were reviewed, including age, birth history, gestational weeks, mode of delivery, SBP, DBP, laboratory indexes (alanine aminotransferase, ALT; aspartate aminotransferase, AST; serum albumin, uric acid and creatinine.), adverse maternal outcomes, adverse fetal outcomes and other information.

PE group

(1) Inclusion criteria: ① All pregnant women meet the diagnostic criteria of preeclampsia. ② Singleton pregnancy. ③ There was no history of primary hypertension, nephropathy and diabetes. ④ The information was complete, including the detection of proteinuria.

(2) Exclusion criteria: ① Multiple pregnancies. ② Patients with primary hypertension, nephropathy and diabetes mellitus. ③ No delivery record due to spontaneous discharge or loss of follow-up. ④ Patients with incomplete laboratory and auxiliary examination data.

(3) Diagnostic criteria of preeclampsia: the diagnostic criteria of preeclampsia refers to the guidelines for diagnosis and treatment of hypertensive disorder in pregnancy (2015 Edition) [11]: Systolic blood pressure (SBP) ≧ 140 mmHg and (or) diastolic blood pressure (DBP) ≧ 90 mmHg after 20 weeks of gestation in a woman with a previously normal blood pressure, accompanied by any of the following: proteinuria ≧ 0.3 g per 24-h collection, or protein/creatinine ≧ 0.3, or dipstick reading ≧ 1+ (methods of examination when urine protein quantification is not possible), or in the absence of proteinuria, new-onset hypertension with the disorder in any one of the following organ or system: heart, lung, liver, kidney and other important organs, or abnormal changes in the blood system, digestive system, nervous system, placental fetal involvement and so on.

(4) Based on the 24-h proteinuria excretion, the PE group was divided into three subgroups: A: mild group, 24-h proteinuria < 0.3 g; B: moderate group, 24-h proteinuria 0.3 ~ 2 g; C: massive group, 24-h proteinuria ≧ 2 g.

Non-PE group

(1) Inclusion criteria: ① Patients with non-gestational hypertension and non-preeclampsia. ② Without proteinuria. ③ Singleton pregnancy. ④ The information was complete, including the detection of proteinuria.

(2) Exclusion criteria: ① Multiple pregnancy. ② Patients with primary hypertension, nephropathy and diabetes mellitus. ③ Those who have no delivery record due to spontaneous discharge or loss of follow-up. ④ The data of laboratory and auxiliary inspection are incomplete.

The definition of adverse pregnancy outcomes [10]

Adverse pregnancy outcomes are referred to severe complications threaten the life of pregnant women or fetus in patients with preeclampsia. Any of the following is defined as an adverse pregnancy outcome: (1) Adverse maternal outcome: Organ dysfunction (kidney, liver or heart failure), eclampsia, HELLP syndrome, hypoproteinemia, pleural or peritoneal effusion or pericardial effusion, oligohydramnios, placental abruption, maternal death, retinal disease, disseminated intravascular coagulation (DIC), postpartum hemorrhage. (2) Adverse fetal outcomes: fetal death, stillbirh, low birth weight, preterm delivery(<37 week), induced labor, fetal growth restriction (FGR), fetal distress, neonatal asphyxia, neonatal hypoxic encephalopathy, fetal malformation.

Statistical analyses

The statistical analyses were performed by the statistical software SPSS24.0. Counting variables were expressed by frequency and analyzed by chi-square test; continuous variables were expressed by Xbar ± s and analyzed by T-test. Correlation analysis was used to analyze the correlation between biochemical indexes and adverse pregnancy outcome, and Logistic regression analysis was used to analyze the risk factors of adverse pregnancy outcome. The receiver operating characteristic curve (ROC) was used to evaluate the ability of 24-h proteinuria to distinguish the adverse pregnancy outcome in patients with preeclampsia. The difference was statistically significant (P <  0.05).

Results

Characteristics of included patients

Table 1 shows clinical characteristics of the 329 pregnant women. Among patients with PE, 170 patients measured 24-h proteinuria, and we divided them into 3 groups according to the degree of 24-h proteinuria (A vs. B vs. C). Group A was defined as proteinuria < 0.3 g/24 h (n = 53, mean 24-h proteinuria = 136.27 ± 89.39 mg/24 h), group B was defined as 0.3 to 2 g/24 h (n = 64, mean 24-h proteinuria = 884.29 ± 538.33 mg/24 h) and group C was defined as proteinuria excretion exceeding 2 g in 24 h (n = 53, mean 24-h proteinuria = 6246.13 ± 5099.54 mg/24 h).

Table 1 Characteristics of included women
Full size table

Between non-PE and PE groups, the maternal age and cesarean section rate were higher in PE group than those in non-PE group (p < 0.001). Laboratory findings such as SBP and DBP at admission, ALT, AST, uric acid and creatinine level in PE group were higher than those in non-PE group (p <  0.001), the albumin level was lower than that of non-PE group (P <  0.001).

Among three subgroups, C group had a shortest gestational week at delivery (p < 0.001). Laboratory findings such as SBP, DBP, uric acid and creatinine were found higher in C group than those in A and B group (p <  0.001). However, other clinical characteristics such as age, birth history, mode of delivery were similar in three groups.

Comparison of adverse pregnancy outcomes in pregnant women

Table 2 shows the adverse maternal outcomes. The incidence of adverse maternal outcome in PE group (92/275, 33.5%) was more than that in non-PE group (2/54,3.7%), (P <  0.001). Compared with non-PE group, PE group had a higher incidence of hypoproteinemia (p = 0.006), organ dysfunction (p = 0.041), retinal disease (p = 0.047). Other adverse maternal outcomes such as pleural and peritoneal effusion, eclampsia, DIC, postpartum hemorrhage, placental abruption and maternal death had no significant difference between two groups (p > 0.05).

Table 2 Comparison of adverse maternal complications
Full size table

In PE subgroups, the incidence of hypoproteinemia, organ dysfunction were significantly different among three groups (A: 5.7%; B: 12.5%; C: 35.8%; p <  0.001 for hypoproteinemia; A: 5.7%; B: 0%; C: 13.2%; p = 0.010 for organ dysfunction). No significant differences were observed in other maternal complications, such as placental abruption, retinal disease. No pregnant women died in the three groups.

Comparison of adverse fetal outcomes among groups

Adverse fetal outcomes are shown in Table 3. The frequencies of adverse fetal outcomes were different in five groups (non-PE group: 24.1% vs. PE group: 45.1%, p = 0.004; group A: 30.2% vs. group B: 30.0% vs. group C: 67.9%, p <  0.001).

Table 3 Comparison of adverse fetal outcomes
Full size table

Between non-PE and PE group, PE group had higher frequencies in premature (p = 0.010), FGA (p = 0.024), low birth weight (p = 0.014), and oligohydramnios (p = 0.012). Among another three subgroups, the rate of induced labour (p = 0.006), premature (p = 0.009), stillbirth (p = 0.001) and birth weight (p = 0.001) have significant difference. Though the incidence of these adverse outcomes didn’t increased with 24-h proteinuria degree, group C seemed to be more likely to develop into adverse fetal outcomes.

Multivariate logistic regression analysis of related predictors and adverse pregnancy outcomes

In order to further determine the impact of proteinuria and other factors on pregnancy outcomes in patients with PE, a correlation test and binary logistics regression analysis were used to analyze parameters which got significance in the univariate analysis. Albumin, uric acid, creatinine, gestational weeks and proteinuria were associated with adverse maternal outcomes in PE patients (albumin: r = − 0.405, p <  0.001; uric acid: r = 0.304, p <  0.001; creatinine r = 0.235, p = 0.003; gestational weeks: r = − 0.236, p = 0.003; proteinuria: r = 0.239, p = 0.002). The factors highly related to the adverse fetal outcome were gestational weeks (r = − 0.463, p <  0.001) and proteinuria (r = 0.336, p <  0.001). Incorporate meaningful indicators of correlation analysis into multivariate logistic analysis, as shown in Table 4, the predictive indicators with statistically significant differences obtained by multivariate regression analysis were albumin, urine acid. Proteinuria was negatively correlated with gestational week (r = − 0.309, p <  0.001) and albumin (r = − 0.360, p <  0.001), suggesting that 24-h proteinuria may have an indirect predictive value for adverse outcomes.

Table 4 Multivariate logistic model predicting adverse outcomes of preeclampsia
Full size table

The best 24-h proteinuria cutoff in preeclampsia to determine adverse outcomes

While studying the relationship between 24-h proteinuria and adverse outcomes in women with preeclampsia, we found there were differences in the incidence of hypoalbuminemia, organ dysfunction, premature delivery and stillbirth in different level of 24-h proteinuria, so we explore the potential diagnostic value of 24-h proteinuria to predict adverse outcomes. Figure 1 (1a to 1b) showed the best 24-h proteinuria cutoff based on ROC curves. The cutoff values to determine stillbirth, premature and fetal distress were 3965.0 mg/24 h, 984.75 mg/24 h and 1503.85 mg/24 h, those corresponding area under the ROC curve (AUC) were 0.816, 0.618 and 0.745 (p <  0.001, p = 0.034 and p = 0.003, respectively) and odds ratios (ORs) (95% confidence interval, CIs) were 12.46 (3.46–44.88), 2.48 (1.15–5.37) and 10.02 (2.14–46.80), respectively. Although univariate analysis showed that there was a difference in the incidence of organ dysfunction among three subgroups, the cutoff value obtained by ROC curve was not significant.

Fig. 1
figure 1

a 24-h proteinuria cutoff value to determine fetal distress. b 24-h proteinuria cutoff value to determine stillbirth

Full size image

Discussion

Previous studies have shown that the degree of 24-h proteinuria is positively correlated with the severity of PE and the occurrence of adverse pregnancy outcomes [5, 12, 13]. Therefore, proteinuria was once considered to be one of the necessary indicators for clinical diagnosis of PE [6]. However, in recent years, the necessity of proteinuria in the diagnosis of PE has been controversial. In a 2010 study [14], researchers showed that PE patients with proteinuria had higher blood pressure and cesarean section rates than PE patients without proteinuria, but proteinuria was not a predictor of adverse pregnancy outcomes. The ACOG (2013) [7] adjusted proteinuria from a necessary index to an additional index in the diagnosis of PE, and deleted 24-h proteinuria ≥5 g from the diagnostic criteria of severe PE since only a minimal relationship existed between proteinuria and adverse pregnancy outcomes. In the latest guideline ACOG (2019) [8], this change in diagnostic criteria is still retained. It suggests that although preeclampsia is usually accompanied by new-onset proteinuria, hypertension and other signs or symptoms of preeclampsia may present in some women without proteinuria. In the absence of proteinuria, new-onset hypertension with the new onset of any of the following can be diagnosed as preeclampsia: thrombocytopenia, renal insufficiency, impaired liver function, pulmonary edema. Chinese guideline for diagnosis and treatment of hypertensive disorder in pregnancy (2015 Edition) also pointed out that proteinuria was not a decisive factor in the diagnosis of PE, but played an important role in evaluating the prognosis of PE [11]. In 2018, The International Society for the Study of Hypertension in Pregnancy (ISSHP) defined presence of proteinuria is not necessary to diagnose preeclampsia [15]. At the same time, some scientists still hold the opinion that proteinuria is closely related to adverse pregnancy outcome in patients with preeclampsia, but few studies proved the relationship between the degree of proteinuria and a specific perinatal / neonatal outcome in women with preeclampsia.

In present study, the rate of cesarean section in PE group was significantly higher than that in non-PE group. This could be because some patients with preeclampsia need to terminate the pregnancy early, but the cervix is not mature, or in severe cases, the pregnancy needs to be terminated immediately. Besides, our results showed the incidence of adverse outcome in PE group was higher than that in non-PE group, including hypoalbuminemia, oligohydramnios, organ dysfunction, retinal disease, premature delivery, FGR, low birth weight, this result is consistent with Homer’s [16], suggesting that PE could be one of the factors affecting pregnancy outcome. PE is a systemic vascular disorder characterized by new-onset hypertension and proteinuria after 20 weeks of gestation, and its basic pathophysiological lesion is systemic arteriolar spasm. Therefor, this disease can affect almost every organ system and lead to complications related to preeclampsia [17]. When renal arterioles are affected, patients may develop a decrease of renal blood perfusion and glomerular filtration rate, as the damage progresses, the basement membrane cells and vascular endothelial cells can be damaged, which results in increased vascular permeability, massive protein loss and proteinuria [17]. A large amount of proteinuria makes pregnant women prone to hypoproteinemia and organ dysfunction. Retinal arteriole spasm can easily lead to retinal detachment. In addition, pregnant women are in a state of hypercoagulability during pregnancy, and the vascular endothelial cell injury in patients with preeclampsia further leads to microvascular thrombosis. Oligohydramnios in patients with preeclampsia may be caused by placental microthrombosis [18]. Combined with the results of the study and the pathological features of PE, proteinuria may be a potential index to predict pregnancy outcomes in preeclampsia patients.

In this study, non-PE patients were limited to undiagnosed preeclampsia and without proteinuria, while not all PE patients had proteinuria according to the 2015 diagnostic guidelines, and there were differences in basic conditions and a variety of biochemical indexes between the two groups, which could not prove a clear relationship between adverse outcome and proteinuria of PE patients. Considering this potential limitation, we performed subgroup analysis and correlation analysis on patients with PE who underwent 24-h proteinuria detection to further explore the relationship between urinary protein and pregnancy outcome. We analyzed 175 PE patients with proteinuria in diffrent degree, and found differences exsisted in the incidence of induced labor, hypoalbuminemia, organ dysfunction, premature delivery and stillbirth in pregnant women with 24-h proteinuria. Contrary to Newman’s [19], Sérgio Hofmeister Martins-Costa’s [20] findings, their studies showed that excessive proteinuria did not mean a more serious outcome, and the increased proteinuria had nothing to do with the risk of adverse outcomes, but in present study, we found the increase of proteinuria could add the rate of adverse outcome of preeclampsia. Moreover, with the increase of the degree of 24-h proteinuria, the incidence of induced labor and stillbirth increased. These results demonstrate that proteinuria may be one of the factors of adverse pregnancy outcome in patients with preeclampsia and this result is consistent with Kumari’s [21] and Chan’s [22].

As reported in our results, the massive group had a shorter gestational week and a higher premature birth rate, but it is still unknown whether this condition is the result of doctors’ choice or whether it is caused by the disease process itself, so we pay more attention to the adverse outcomes that are less affected by artificial manipulation. We used correlation analysis to explore the relative factors of adverse pregnancy outcome in patients with preeclampsia. The results showed that 24-h proteinuria, serum albumin, creatinine, uric acid and gestational week were all related to adverse pregnancy outcome. Binary logistic regression analysis results showed the predictive indicators with statistically significant differences were albumin, urine acid. The accuracy of the model predicting the adverse maternal outcome and adverse fetal outcome were 72.6, 68.2%, respectively. In our study, 24-h proteinuria was negatively correlated with albumin, it means we cannot deny the role of 24-h proteinuria in predicting adverse outcomes in patients with preeclampsia.

For decades, few studies have demonstrated a clear relationship between the degree of proteinuria and a specific perinatal / neonatal outcome in women with preeclampsia. In 2020, Mamoru Morikawa et al. [23] first demonstrated the relationship between the severity of the Protein: Creatinine (P/C) ratio at delivery and perinatal / neonatal outcomes among women with preeclampsia based on a ROC curve, the best P/C ratio cutoff values in preeclampsia to determine early preterm birth (EPB) and maternal central serous chorioretinopathy (CSC) were 4.1 and 4.8, respectively. The results indicated that the best cutoff value of the P/C ratio at delivery for worsened perinatal outcomes in women with preeclampsia was 4.8. In present study, we used the ROC curve to analyze the relationship between 24-h proteinuria and adverse outcomes of patients with preeclampsia, and obtained the corresponding cutoff value. The cutoff value to determine hypoproteinemia, stillbirth, preterm birth and intrauterine distress were 1935 mg/24 h, 3965.0 mg/24 h, 984.75 mg/24 h and 1503.85 mg/24 h, respectively. Obviously, the cutoff values of 24-h proteinuria varies from different adverse outcomes, this may be one of the reasons for the controversy in the application of urine protein in preeclampsia. These cutoff values may be limited in clinical application, but it is undeniable that proteinuria has been once again confirmed to be associated with adverse outcomes, which also suggests that doctors still need to be vigilant about proteinuria in the treatment of patients with PE.

Conclusions

In conclusion, the increase of 24-h proteinuria may lead to an increase in the incidence of adverse outcomes in women with preeclampsia. We suggest that proteinuria should be retained as one of the monitoring indexes for patients with preeclampsia. However, the pregnancy outcome of patients with preeclampsia is affected by many factors, so the monitoring of proteinuria combined with the consideration of complications and other laboratory indicators may have a more accurate prediction of adverse pregnancy outcomes.

Availability of data and materials

Not applicable.

Abbreviations

ACOG:

American College of Obstetricians and Gynecologists

ALT:

Alanine Aminotransferase

AST:

Aspartate aminotransferase

AUC:

Area Under Curve

CI:

Confidence Interval

DBP:

Diastolic Blood Pressure

DIC:

Disseminated Intravascular Coagulation

EPB:

Early Preterm Birth

FGR:

Fetal Growth Restriction

ORs:

Odds Ratio

P/C Ratio:

Protein Creatinine Ratio

PE:

Pre-eclampsia

ROC:

The Receiver Operating Characteristic curve

SBP:

Systolic Blood Pressure

References

  1. Lin S, Leonard D, Co MA, Mukhopadhyay D, Giri B, Perge L, et al. Pre-eclampsia has an adverse impact on maternal and fetal health. Transl Res. 2015;165(4):449–63. https://doi.org/10.1016/j.trsl.2014.10.006.

    Article  PubMed  Google Scholar 

  2. Fishel Bartal M, Lindheimer MD, Sibai BM. Proteinuria during pregnancy: definition, pathophysiology, methodology, and clinical significance. Am J Obstet Gynecol. 2020. https://doi.org/10.1016/j.ajog.2020.08.108.

  3. Cai J, Wang T, Li M, Cheng X, Zhang Y. Isolated proteinuria in Chinese pregnant women with pre-eclampsia: results of retrospective observational study. Biomed Res. 2015;28(11):5162–6.

    Google Scholar 

  4. Ekiz A, Kaya B, Polat I, Avci ME, Ozkose B, Kicik Caliskan R, et al. The outcome of pregnancy with new onset proteinuria without hypertension: retrospective observational study. J Matern Fetal Neonatal Med. 2016;29(11):1765–9. https://doi.org/10.3109/14767058.2015.1061497.

    Article  CAS  PubMed  Google Scholar 

  5. Mateus J, Newman R, Sibai BM, et al. Massive Urinary Protein Excretion Associated with Greater Neonatal Risk in Preeclampsia. AJP Rep. 2017. https://doi.org/10.1055/s-0037-1601866.

  6. Pregnancy Hypertension Group of Obstetrics and Gynecology Branch of Chinese Medical Association. Guidelines for the Diagnosis and Treatment of Hypertensive Disorders Complicating Pregnancy (2012). Chin J Obstetrics Gynecol. 2012. https://doi.org/10.3760/cma.j.issn.0529-567x.2012.06.018.

  7. American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122(5):1122–31.

    Article  Google Scholar 

  8. Practice Bulletin No ACOG. 202: gestational hypertension and preeclampsia. Obstet Gynecol. 2019;133(1):1. https://doi.org/10.1097/AOG.0000000000003018 PMID: 30575675.

    Article  Google Scholar 

  9. Shinar S, Asher-Landsberg J, Schwartz A, Ram-Weiner M, Kupferminc MJ, Many A. Isolated proteinuria is a risk factor for pre-eclampsia: a retrospective analysis of the maternal and neonatal outcomes in women presenting with isolated gestational proteinuria. J Perinatol. 2016;36(1):25–9. https://doi.org/10.1038/jp.2015.138.

    Article  CAS  PubMed  Google Scholar 

  10. Bouzari Z, Javadiankutenai M, Darzi A, Barat S. Does proteinura in preeclampsia have enough value to predict pregnancy outcome? Clin Exp Obstet Gynecol. 2014;41(2):163–8.

    CAS  PubMed  Google Scholar 

  11. Pregnancy Hypertension Group of Obstetrics and Gynecology Branch of Chinese Medical Association. Guidelines for the diagnosis and treatment of hypertensive disorders complicating pregnancy (2015). Chin J Obstet Gynecol. 2016;019(003):161–9.

    Google Scholar 

  12. Rezk M, Abo-Elnasr M, Al Halaby A, Zahran A, Badr H. Maternal and fetal outcome in women with gestational hypertension in comparison to gestational proteinuria: a 3-year observational study. Hypertens Pregnancy. 2016;35(2):181–8. https://doi.org/10.3109/10641955.2015.1130832.

    Article  CAS  PubMed  Google Scholar 

  13. Kate B, Carlos E, Poli-de-Figueiredo P, et al. Association of proteinuria threshold in pre-eclampsia with maternal and perinatal outcomes: a nested case control cohort of high risk women. PLoS One. 2013;8(10):e76083. https://doi.org/10.1371/journal.pone.0076083.

    Article  CAS  Google Scholar 

  14. Thornton CE, Makris A, Ogle RF, Tooher JM, Hennessy A. Role of proteinuria in defining pre-eclampsia: Clinical outcomes for women and babies. Clin Exp Pharmacol Physiol. 2010;37(4):466–70. https://doi.org/10.1111/j.1440-1681.2009.05334.x.

    Article  CAS  PubMed  Google Scholar 

  15. Brown Mark A, Magee Laura A, Kenny Louise C, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international Practice. Hypertension. 2018;72(1):24–43. https://doi.org/10.1161/HYPERTENSIONAHA.117.10803.

    Article  CAS  PubMed  Google Scholar 

  16. Homer CS, Brown MA, Mangos G, Davis GK. Non-proteinuric pre-eclampsia: a novel risk indicator in women with gestational hypertension. J Hypertens. 2008;26(2):295–302. https://doi.org/10.1097/HJH.0b013e3282f1a953.

    Article  CAS  PubMed  Google Scholar 

  17. Tomimatsu T, Mimura K, Matsuzaki S, Endo M, Kumasawa K, Kimura T. Preeclampsia: maternal systemic vascular disorder caused by generalized endothelial dysfunction due to placental Antiangiogenic factors. Int J Mol Sci. 2019;20(17):4246. https://doi.org/10.3390/ijms20174246.

    Article  CAS  PubMed Central  Google Scholar 

  18. Yang Z. Etiology and Management of Oligohydramnios. J Pract Obstet Gynecol. 2008;24(004):197–9.

    Google Scholar 

  19. Newman MG, Robichaux AG, Stedman CM, Jaekle RK, Fontenot MT, Dotson T, et al. Perinatal outcomes in preeclampsia that is complicated by massive proteinuria. Am J Obstet Gynecol. 2003;188(1):264–8. https://doi.org/10.1067/mob.2003.84.

    Article  PubMed  Google Scholar 

  20. Martins-Costa SH, Vettorazzi J, Valério E, Maurmman C, Benevides G, Hemessath M, et al. Protein creatinine ratio in random urine sample of hypertensive pregnant women: maternal and perinatal outcomes. Hypertens Pregnancy. 2011;30(3):331–7. https://doi.org/10.3109/10641950903454564.

    Article  CAS  PubMed  Google Scholar 

  21. Kumari A, Chakrawarty A, Singh A, Singh R. Maternofoetal complications and their association with proteinuria in a tertiary care hospital of a developing country. J Pregnancy. 2014;2014:431837.

    Article  Google Scholar 

  22. Chan P, Brown M, Simpson JM, Davis G. Proteinuria in pre-eclampsia: how much matters? BJOG. 2005;112(3):280–5. https://doi.org/10.1111/j.1471-0528.2004.00395.x.

    Article  PubMed  Google Scholar 

  23. Morikawa M, Mayama M, Saito Y, Nakagawa K, Umazume T, Chiba K, et al. Severe proteinuria as a parameter of worse perinatal/neonatal outcomes in women with preeclampsia. Pregnancy Hypertens. 2020;19:119–26. https://doi.org/10.1016/j.preghy.2019.12.013.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Not applicable.

Authors` contributions

All authors contributed to the article. TL, TQ, WL and XL contributed to the study conception and designed the study. TL, TQ and WL collected and summarized all epidemiological and clinical data. XL and HH provided summaries of previous research studies. TL, TQ, WL, KL contributed to the statistical analysis. TL, KL and LC revised the final manuscript. All authors read and approved of the final manuscript.

Funding

This work was supported by The project of Tutorial System of Medical Undergraduate in Lab Teaching & Management Center in Chongqing Medical University (Grant NO. LTMCMTS202001).

Author information

Authors and Affiliations

  1. First Clinical College, Chongqing Medical University, Chongqing, China

    Tingting Lei, Ting Qiu, Wanyu Liao & Xinyue Lai

  2. School of Public Health and Management, Chongqing Medical University, Chongqing, China

    Kangjie Li

  3. Second Clinical College, Chongqing Medical University, Chongqing, China

    Hongbo Huang

  4. Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing Univ-ersity Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, Chongqing, China

    Rui Yuan

  5. The Center of Experimental Teaching Management, Chongqing Medical University, Chongqing, China

    Ling Chen

Authors
  1. Tingting Lei
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ting Qiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wanyu Liao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kangjie Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xinyue Lai
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hongbo Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Rui Yuan
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ling Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ling Chen.

Ethics declarations

Ethics approval and consent to participate

No patient consent was required for this retrospective cohort study.

Consent for publication

All authors have reviewed the manuscript and consent for publication.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1:

Correlation test between various diagnostic indicators and adverse outcomes. Relationship between 24 h urine protein cutoff value based on ROC curve and pregnant outcomes. Fig1. 24 h proteinuria cutoff value to determing hypoproteinemia. Fig2. 24 h proteinuria cutoff value to determine adverse outcomes.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lei, T., Qiu, T., Liao, W. et al. Proteinuria may be an indicator of adverse pregnancy outcomes in patients with preeclampsia: a retrospective study. Reprod Biol Endocrinol 19, 71 (2021). https://doi.org/10.1186/s12958-021-00751-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12958-021-00751-y

Keywords

Reproductive Biology and Endocrinology

ISSN: 1477-7827

Contact us